Text this: Monitoring Immune Dysfunction in Critically Ill Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Sepsis Treated with Regimens Including Cefiderocol: A Pilot Study to Identify Accessible Biomarkers to Stratify Patients’ Prognosis